source
- Prime Medicine clears legal hurdle with Beam Therapeutics, moves AATD gene therapy toward clinicPrime Medicine announced it will advance its AATD gene editing candidate into clinical trials after arbitrators ruled in its favor in a dispute with Beam Therapeutics. The dispute centered on a 20…
- Novartis announces reduction of 322 jobs at New Jersey facilityNovartis filed a WARN notice indicating it will eliminate 322 positions at its East Hanover, New Jersey site. The reduction is part of a broader restructuring effort aimed at streamlining operation…